CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 406 enrolled
Drug / intervention
Femtosecond laser +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02403206
NCT02403206N/ACompleted
CompareCT.gov

Femtosecond Laser Assisted Cataract Surgery in Intumescent Cataracts

Alcon, a Novartis Company·interventional·Posted Mar 31, 2015·Updated Jul 2, 2018

In Brief

A clinical study evaluating Femtosecond laser and Continuous Curvilinear Capsulorhexis (CCC) for Intumescent Cataract. Completed, enrolled 406 participants.

Detailed Summary

The purpose of the study is to compare femtosecond laser-assisted capsulotomy to manual capsulorhexis in patients with intumescent cataracts. An intumescent cataract is defined as a cataract with a pressurized capsular bag.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIntumescent Cataract
Countries--
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 31, 2015
Enrollment StartMar 26, 2015
Primary CompletionJul 12, 2016
Study CompletionAug 24, 2016
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 11.3 years ago

Interventions

Femtosecond laserdevice

Laser console and a patient interface used to cut tissue during cataract removal of the crystalline lens

Continuous Curvilinear Capsulorhexis (CCC)procedure

Standard-of care manual procedure (using either needles or forceps) for creating capsulorhexis, ie., opening in capsular bag during anterior segment ophthalmic surgery